Cullgen
Latest round
- Series C
Last raised
- May 2023
Total raised
- $101M
Investors
- 12
About Cullgen
Founded in 2018 by Jian Jin and Yue Xiong and based in California, US, Cullgen Inc. operates as a biopharmaceutical company that manufactures medical drugs for cancer and autoimmune diseases using uSMITE™, a protein degradation technology. In May 2023, Cullgen Inc., Heights Capital Management, HighLight Capital, MSA Capital, Octagon Capital Advisors, Sequoia Capital, Sincere Capital, South China Venture Capital, Voyagers Capital, and Wuxi Venture Capital Group, agreed to merge with Pulmatrix, Inc. Following the transaction, the combined entity will operate under Cullgen Inc. Financial terms were not disclosed. The company provides drug discovery services that are intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use a targeted protein degradation technology, uSMITE™ that produces precision medicine with the potential to address a broad range of intracellular disease targets, such as oncology, inflammation, CNS, and other diseases that cannot be addressed by existing therapies. The company’s service enables scientists to develop novel therapeutic approaches for various diseases. The company is developing a number of uSMITE™ based therapeutics in-house, primarily for oncology. The company’s advanced candidate, CG001419, is in pre-clinical studies.
Who invested in Cullgen
12 investors across 3 rounds
See all investors in Cullgen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cullgen
Who invested in Cullgen?
Cullgen has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cullgen raised?
Cullgen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cullgen last raise money?
Cullgen's most recent round on record is a Series C, in May 2023.
What does Cullgen do?
Founded in 2018 by Jian Jin and Yue Xiong and based in California, US, Cullgen Inc.
Where is Cullgen headquartered?
Cullgen is headquartered in San Diego, US.
Which VCs invest in companies like Cullgen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cullgen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Cullgen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.